PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMesna
Mesna
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
347 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.9265952685
Multiple myelomaD009101—C90.081221—19
Germ cell and embryonal neoplasmsD009373——3611312
Plasma cell neoplasmsD054219——3721—11
SclerosisD012598——4441—11
T-cell lymphomaD016399——17—2—9
Systemic sclerodermaD012595EFO_0000717M343331—8
Diffuse sclerodermaD045743EFO_0000404—3331—8
T-cell lymphoma peripheralD016411——15—2—7
MedulloblastomaD008527——122117
Show 4 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C9529486—475
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.015324—145
SarcomaD012509——12197—437
NeoplasmsD009369—C8019201—335
Non-hodgkin lymphomaD008228—C85.913261—334
Lymphoid leukemiaD007945—C9112244——34
Myelodysplastic syndromesD009190—D4610171—225
Myeloid leukemia acuteD015470—C92.010151—124
Myeloid leukemiaD007951—C928181——24
Breast neoplasmsD001943EFO_0003869C507152——18
Show 38 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hematologic neoplasmsD019337——1219——124
MelanomaD008545——915——122
Neoplasm metastasisD009362EFO_0009708—1112——118
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340—212———12
SyndromeD013577——28——19
B-cell chronic lymphocytic leukemiaD015451—C91.129———9
Myelomonocytic leukemia juvenileD054429—C93.337———8
Primary myelofibrosisD055728—D47.435———8
Ovarian neoplasmsD010051EFO_0003893C5636———7
Pancreatic neoplasmsD010190EFO_0003860C2556———7
Show 138 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Wilms tumorD009396EFO_0000212—2————2
Rhabdoid tumorD018335——1———12
GanglioneuroblastomaD018305——1————1
Metabolic syndromeD024821EFO_0000195E88.8101————1
VasculitisD014657EFO_0006803M311————1
MyositisD009220EFO_0000783G72.491————1
Muscular diseasesD009135EFO_0002970G72.91————1
ObesityD009765EFO_0001073E66.91————1
Myasthenia gravisD009157EFO_0004991G70.01————1
Muscle weaknessD018908——1————1
Show 9 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NauseaD009325—R11.0————22
Drug-related side effects and adverse reactionsD064420—T88.7————11
AggressionD000374EFO_0003015—————11
HistiocytosisD015614HP_0100727—————11
Langerhans-cell histiocytosisD006646—C96.6————11
Wiskott-aldrich syndromeD014923EFO_0003903D82.0————11
Severe combined immunodeficiencyD016511—D81.0————11
Hemophagocytic lymphohistiocytosisD051359—D76.1————11
Chronic granulomatous diseaseD006105EFO_0000338D71————11
Type 1 hyper-igm immunodeficiency syndromeD053307——————11
Show 12 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
6,544 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use